CSS
PRCT icon

Cubist Systematic Strategies’s Procept Biorobotics PRCT Stock Holding History

Cubist Systematic Strategies’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-103,504
Closed -$5.12M – 3798
2024
Q1 		$5.12M Buy
103,504
+96,634
+1,407% +$4.6M 0.03% 950
2023
Q4 		$288K Buy
+6,870
New +$234K ﹤0.01% 2811
2023
Q2 		– Sell
-33,392
Closed -$948K – 4141
2023
Q1 		$948K Buy
33,392
+24,487
+275% +$864K 0.01% 2224
2022
Q4 		$370K Sell
8,905
-24,995
-74% -$1.07M ﹤0.01% 3226
2022
Q3 		$1.41M Sell
33,900
-11,731
-26% -$468K 0.01% 2329
2022
Q2 		$1.49M Buy
45,631
+20,844
+84% +$758K 0.01% 2130
2022
Q1 		$867K Buy
24,787
+8,425
+51% +$203K 0.01% 2146
2021
Q4 		$409K Buy
16,362
+15,343
+1,506% +$568K ﹤0.01% 2595
2021
Q3 		$39K Buy
+1,019
New +$39.1K ﹤0.01% 2857

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Cubist Systematic Strategies's PRCT Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of Procept Biorobotics (PRCT) in Q2 2024, closing a stake of 103,504 shares — an estimated $5.12M sold.

Cubist Systematic Strategies first reported a position in PRCT in Q3 2021 and held it in 9 quarters. The position peaked at $5.12M in Q1 2024. 201 funds tracked by Wall St. Rank hold PRCT as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining Procept Biorobotics position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 103,504 Procept Biorobotics shares in Q2 2024, an estimated $5.12M.
  • Cubist Systematic Strategies first reported a position in Procept Biorobotics in Q3 2021 and held it in 9 quarters.
  • Cubist Systematic Strategies's Procept Biorobotics position peaked at $5.12M in Q1 2024.
  • 201 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.